Search

everythinglearnresearchcommunity

for

Search:↓

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Finasteride, a medication, is being re-evaluated for its effects and uses.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Finasteride can cause itching, burning, and other side effects that may not go away after treatment.

Dutasteride is approved to help manage prostate enlargement.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

Certain hormone treatments can improve acne and related conditions in women.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

11-oxyandrogens are linked to excess hair growth in PCOS, but don't help diagnose it.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Finasteride helps prevent kidney stones, but side effects need more research.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Cyclosporin doesn't stop hair loss.

The combination treatment showed a higher response rate but no significant survival benefits.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

New compounds with carborane showed anti-androgen effects similar to flutamide.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.